Humana (NYSE:HUM) Raised to “Strong-Buy” at Zacks Research

by · The Markets Daily

Humana (NYSE:HUM – Get Free Report) was upgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a research note issued to investors on Monday,Zacks.com reports.

HUM has been the topic of a number of other research reports. Weiss Ratings raised Humana from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 29th. Royal Bank Of Canada upped their price target on Humana from $246.00 to $415.00 and gave the company a “sector perform” rating in a research report on Thursday, July 9th. JPMorgan Chase & Co. raised their price objective on Humana from $214.00 to $316.00 and gave the stock a “neutral” rating in a research note on Monday, June 8th. Wolfe Research raised shares of Humana from a “hold” rating to a “strong-buy” rating in a report on Thursday, June 4th. Finally, Needham & Company LLC initiated coverage on shares of Humana in a research note on Wednesday, May 20th. They set a “buy” rating for the company. Two investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, fifteen have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $325.87.

Read Our Latest Report on HUM

Humana Stock Performance

Shares of Humana stock opened at $406.70 on Monday. The firm has a market cap of $48.83 billion, a PE ratio of 43.50, a price-to-earnings-growth ratio of 2.31 and a beta of 0.71. The firm’s 50-day simple moving average is $345.52 and its 200-day simple moving average is $257.26. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. Humana has a 1 year low of $163.11 and a 1 year high of $415.00.

Humana (NYSE:HUM – Get Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company’s revenue for the quarter was up 23.5% compared to the same quarter last year. During the same period last year, the firm earned $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. Equities analysts forecast that Humana will post 9.03 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Aberdeen Group plc raised its holdings in shares of Humana by 18.1% during the fourth quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock valued at $72,684,000 after buying an additional 43,442 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in Humana by 4.1% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock worth $66,207,000 after buying an additional 9,960 shares in the last quarter. Ninety One UK Ltd grew its holdings in Humana by 57.2% in the 4th quarter. Ninety One UK Ltd now owns 112,501 shares of the insurance provider’s stock worth $28,815,000 after buying an additional 40,958 shares in the last quarter. Sustainable Insight Capital Management LLC increased its position in Humana by 23.7% in the 4th quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock valued at $6,341,000 after acquiring an additional 4,740 shares during the period. Finally, Wealth Enhancement Advisory Services LLC increased its position in Humana by 287.5% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 52,512 shares of the insurance provider’s stock valued at $14,699,000 after acquiring an additional 38,962 shares during the period. 92.38% of the stock is currently owned by institutional investors.

About Humana

(Get Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Recommended Stories